These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9888841)

  • 1. Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists.
    Greenspan PD; Fujimoto RA; Marshall PJ; Raychaudhuri A; Lipson KE; Zhou H; Doti RA; Coppa DE; Zhu L; Pelletier R; Uziel-Fusi S; Jackson RH; Chin MH; Kotyuk BL; Fitt JJ
    J Med Chem; 1999 Jan; 42(1):164-72. PubMed ID: 9888841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships.
    Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain.
    Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA
    J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
    Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
    J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
    Nakayama Y; Senokuchi K; Sakaki K; Kato M; Maruyama T; Miyazaki T; Ito H; Nakai H; Kawamura M
    Bioorg Med Chem; 1997 May; 5(5):971-85. PubMed ID: 9208106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.
    Goodnow RA; Hicks A; Sidduri A; Kowalczyk A; Dominique R; Qiao Q; Lou JP; Gillespie P; Fotouhi N; Tilley J; Cohen N; Choudhry S; Cavallo G; Tannu SA; Ventre JD; Lavelle D; Tare NS; Oh H; Lamb M; Kurylko G; Hamid R; Wright MB; Pamidimukkala A; Egan T; Gubler U; Hoffman AF; Wei X; Li YL; O'Neil J; Marcano R; Pozzani K; Molinaro T; Santiago J; Singer L; Hargaden M; Moore D; Catala AR; Chao LC; Hermann G; Venkat R; Mancebo H; Renzetti LM
    J Med Chem; 2010 May; 53(9):3502-16. PubMed ID: 20380377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
    Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM
    J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the spatial arrangement of the two acid-binding sites on the human neutrophil LTB4 receptor.
    Chaney MO; Froelich LL; Gapinski DM; Mallett BE; Jackson WT
    Receptor; 1992; 2(3):169-79. PubMed ID: 1335328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate.
    Hullot P; Poudrel JM; Muller A; Escale R; Rossi JC; Girard JP; Bonne C
    Arzneimittelforschung; 1997 Jan; 47(1):51-8. PubMed ID: 9037445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Tzimas MN; Martin LD; Daines RA; Chambers PA; Kingsbury WD; Griswold DE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():275-7. PubMed ID: 7732852
    [No Abstract]   [Full Text] [Related]  

  • 13. trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.
    Reiter LA; Koch K; Piscopio AD; Showell HJ; Alpert R; Biggers MS; Chambers RJ; Conklyn MJ; Cooper K; Cortina SR; Dibrino JN; Dominy BW; Farrell CA; Hingorani GP; Martinelli GJ; Ramchandani M; Wright KF
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1781-6. PubMed ID: 9873433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.
    Poudrel JM; Hullot P; Vidal JP; Girard JP; Rossi JC; Muller A; Bonne C; Bezuglov V; Serkov I; Renard P; Pfeiffer B
    J Med Chem; 1999 Dec; 42(26):5289-310. PubMed ID: 10639274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of structural analogs of leukotriene B4 and their receptor binding activity.
    Kingsbury WD; Pendrak I; Leber JD; Boehm JC; Mallet B; Sarau HM; Foley JJ; Schmidt DB; Daines RA
    J Med Chem; 1993 Oct; 36(22):3308-20. PubMed ID: 8230121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enaminone amides as novel orally active GABAA receptor modulators.
    Hogenkamp DJ; Johnstone TB; Huang JC; Li WY; Tran M; Whittemore ER; Bagnera RE; Gee KW
    J Med Chem; 2007 Jul; 50(14):3369-79. PubMed ID: 17571865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.